Right to Try for Individualized Treatments Act

TL;DR (AI)

• The bill authorizes the use of investigational individualized medical treatments for patients diagnosed with a life-threatening disease or severely debilitating illness who have exhausted approved treatment options.
• Eligible patients must provide informed consent to receive these treatments, which are defined as drugs or biological products based on a patient's unique genomic profile.
• Manufacturers of investigational individualized medical treatments are permitted, but not required, to make such treatments available to eligible patients within eligible health care facilities.